These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 484566)

  • 41. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Minimizing aminoglycoside toxicity by prescriber notification of prolonged therapy.
    Brown G
    Hosp Pharm; 1995 Jan; 30(1):33-6. PubMed ID: 10139728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A microcomputer spreadsheet for aminoglycoside kinetics.
    Kiacz BJ
    Hosp Pharm; 1990 May; 25(5):450-3. PubMed ID: 10104824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Enzymatic assays of aminoglycoside antibiotics (author's transl)].
    Kayser FH
    Infection; 1977; 5(2):123-5. PubMed ID: 881263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapy.
    Fant WK
    Am J Hosp Pharm; 1986 Mar; 43(3):641-6. PubMed ID: 3706319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multidisciplinary approach to enhance documentation of antibiotic serum sampling.
    Sieradzan R; Fuller AV
    Hosp Pharm; 1995 Oct; 30(10):872, 874, 876-7. PubMed ID: 10151951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality assurance and certification program for an aminoglycoside monitoring service.
    Shevchuk YM; Poulin S
    Can J Hosp Pharm; 1990 Apr; 43(2):49-55. PubMed ID: 10106632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of an aminoglycoside kinetic service on aminoglycoside use in a community hospital.
    Cahill RJ; Myers RM; Bauer LA; Alston RM
    Hosp Pharm; 1986 Aug; 21(8):734-7. PubMed ID: 10277582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.
    McCormack JP; Schentag JJ
    Drug Intell Clin Pharm; 1987 Feb; 21(2):187-92. PubMed ID: 3829911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality assurance of data collection in an aminoglycoside dosing service.
    Lew KH; Malyuk DL
    Can J Hosp Pharm; 1991 Oct; 44(5):239-43. PubMed ID: 10115577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of serum concentrations of some aminoglycoside antibiotics by use of the fluorescent immunoassay method.
    Dzierzanowska D; Nowik-Jurek M; Podleśny J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):389-94. PubMed ID: 6651487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicians' perceptions of the effect of a pharmacokinetic service on their ability to independently function.
    Lackner TE; Manchester R
    Hosp Pharm; 1991 Jul; 26(7):618, 632. PubMed ID: 10111795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of aminoglycoside-use restrictions on drug cost.
    DeTorres OH; White RE
    Am J Hosp Pharm; 1984 Jun; 41(6):1137-9. PubMed ID: 6430070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
    Gorsky JE; Latts JR
    Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic monitoring of aminoglycoside treatment. The value of early clinical contact].
    Olesen B; Frimodt-Møller N
    Ugeskr Laeger; 1991 Jun; 153(23):1651-2. PubMed ID: 2058028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacist-managed aminoglycoside therapy in combination with a beta-lactam agent in the treatment of nosocomial pneumonia in critically ill patients.
    Wade WE; McCall CY
    Pharmacotherapy; 1995; 15(2):216-9. PubMed ID: 7624269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Justification and evaluation of an aminoglycoside pharmacokinetic dosing service.
    Jorgenson JA; Rewers RF
    Hosp Pharm; 1991 Jul; 26(7):605, 609-11, 615. PubMed ID: 10111793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.